Alpha DNA Investment Management’s Sempra SRE Stock Holding History
Bought
Maintained
Sold
Other funds holding SRE
Alpha DNA Investment Management's SRE Position: Q2 2021 in Review
Alpha DNA Investment Management sold out of Sempra (SRE) in Q2 2021, closing a stake of 1,808 shares — an estimated $119K sold.
Alpha DNA Investment Management first reported a position in SRE in Q4 2020 and held it in 2 quarters. The position peaked at $119K in Q1 2021. 816 funds tracked by Wall St. Rank hold SRE as of Q2 2021.
- Alpha DNA Investment Management reported no remaining Sempra position as of Q2 2021 after selling out during the quarter.
- Alpha DNA Investment Management sold 1,808 Sempra shares in Q2 2021, an estimated $119K.
- Alpha DNA Investment Management first reported a position in Sempra in Q4 2020 and held it in 2 quarters.
- Alpha DNA Investment Management's Sempra position peaked at $119K in Q1 2021.
- 816 funds tracked by Wall St. Rank held Sempra as of Q2 2021.
Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.